PHARMACISTS can have a key
role in advising patients with
papulopustular rosacea (PPR) on
the use of a new anti-inflammatory
and antimicrobial prescription
therapy known as Soolantra
Cream (ivermectin 1%), according
to Sydney dermatologist Dr John
Sullivan, who said the medication
has been shown to provide
“sustained efficacy and effectiveness
in delaying relapse rates”.
“Pharmacists are well placed to
identify the signs and subtypes of
rosacea and advise on the need to
see a doctor,” he said.
Soolantra has shown superior
skin clearance rates to topical
metronidazole, Sullivan added.
The topical product is applied on
a daily basis for up to four months
before assessing whether a repeat
course of therapy is required.
This product is not PBS listed.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Apr 16
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.